3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
27
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
18
Melanoma
13
Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Recurrent Squamous Cell Lung Carcinoma
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Locally Advanced Melanoma
1
Locally Advanced Gastric Cancer
1
Liver Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Eunuchism
1
Esophageal Neoplasms
1
Erectile Dysfunction
1
Interventions
Surgical Procedures, Operative
7
Liver Transplantation
5
Lenalidomide
4
Blood Specimen Collection
4
pomalidomide
3
Neoadjuvant Therapy
3
Liquid Biopsy
3
gilteritinib
2
Therapeutics
2
Rituximab
2
Proteasome Inhibitors
2
Observation
2
Mohs Surgery
2
Mitomycin
2
Magnetic Resonance Spectroscopy
2
Immunotherapy, Adoptive
2
Immunoconjugates
2
High-Throughput Nucleotide Sequencing
2
Fluorouracil
2
Drug Therapy
2
DNA, Mitochondrial
2
Brentuximab Vedotin
2
Bendamustine Hydrochloride
2
Antibodies, Monoclonal
2
Antibodies, Bispecific
2
Amplified Fragment Length Polymorphism Analysis
2
trametinib
1
romidepsin
1
nedaplatin
1
lenvatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Recurrence
×
Nivolumab
×
Clear all
NCT05068609
2022-05-05
VOLUME-PRO
Bristol-Myers Squibb
Completed
509 enrolled